The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Merck announced the company is discontinuing development of its SARS-CoV-2/COVID-19 vaccine candidates, V590 and V591.
read more
Antios Therapeutics has completed the Phase 1b clinical trial of ATI-2173, an ASPIN in patients with chronic hepatitis B virus infection.
read more
Jubilant Therapeutics announced a collaboration with The Wistar Institute to evaluate PAD4 inhibitors to block NET formation in the context of COVID-...
read more
ConserV Bioscience Limited and LLNL have agreed to collaborate on the development of a broad-spectrum coronavirus vaccine.
read more
Thursday, January 21, 2021
Bamlanivimab (LY-CoV555) significantly reduced the risk of contracting symptomatic COVID-19 among residents and staff of long-term care facilities.
read more
Thursday, January 21, 2021
Pfizer and BioNTech announced results from an in vitro study that provides additional data on the capability of sera from individuals immunized with ...
read more
Wednesday, January 20, 2021
Therapeutic Solutions International announced positive preliminary data from the Federally listed clinical trial "Correlation of Campbell Score with ...
read more
Wednesday, January 20, 2021
Steba biotech announced the FDA has granted Fast Track designation for padeliporfin ImPACT for the treatment of low-grade and unifocal high-grade ...
read more
Tuesday, January 19, 2021
Gritstone Oncology is advancing development of a second-generation vaccine against SARS-CoV-2 with potential for both prolonged protection and potency...
read more
Tuesday, January 19, 2021
Creative Medical Technology Holdings announced positive data and filing of a patent application covering the use of ImmCelz in prevention and ...
read more
Amydis announced successful completion of pre-IND meeting with the FDA regarding the development plan for AMDX-2011P, a small-molecule retinal tracer ...
read more
Thursday, January 14, 2021
AbbVie announced positive results from two Phase 3 induction studies, ADVANCE and MOTIVATE, showing both doses of risankizumab met both primary ...
read more
Wednesday, January 13, 2021
Ambrx announced the FDA granted ARX788 Fast Track Designation as monotherapy for the treatment of advanced or metastatic HER2-positive breast cancer ...
read more
Wednesday, January 13, 2021
BlueRock in collaboration with MSK, announced the FDA has cleared their IND application to proceed with a Phase 1 study in patients with advanced ...
read more
Bioniz announced the FDA provided positive feedback during the company's end of Phase 2 meeting for Bioniz's BNZ-1.
read more